Anti-bèta-Hydroxybutyryl-Histone H3 (Lys9) Rabbit mAb
PTM-1250RM
ApplicationsWestern Blot, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Rat
Overview
- SupplierPTM BIO
- Product NameAnti-bèta-Hydroxybutyryl-Histone H3 (Lys9) Rabbit mAb
- Delivery Days Customer5
- Antibody SpecificityAnti-bèta-Hydroxybutyryl-Histone H3 (Lys9) Rabbit mAb detects histone H3 only when it is bèta-hydroxybutyrylated at Lys9. This antibody has been shown to selectively recognize bèta-hydroxybutyrylated H3 peptide at Lys9, but not the acetylated, crotonylated, butyrylated, 2-hydroxyisobutyrylated, or unmodified H3 peptide at Lys9 or Lys27.
- ApplicationsWestern Blot, ImmunoHistoChemistry Paraffin
- Applications SupplierWB, IHC-P
- Category SupplierAntibody
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDPA-022-8
- ConjugateUnconjugated
- HostRabbit
- IsotypeIgG
- Protein IDP68431
- Protein NameHistone H3.1
- Scientific DescriptionHistones are subject to a variety of enzyme catalyzed modifications, including acetylation, methylation, Phosphorylatedrylation, ubiquitination, and numerous others. bèta-Hydroxybutyrylation of lysine (Kbhb) is a newly identified histone marker that is enriched in active gene promoters. Histone Kbhb marks are dramatically induced in response to elevated bèta-hydroxybutyrate levels in cultured cells and in livers from mice subjected to prolonged fasting or streptozotocin-induced diabetic ketoacidosis. Histone bèta-hydroxybutyrylation represents a new epigenetic regulatory mark that couples metabolism to gene expression, offering a new avenue to study chromatin regulation and diverse functions of bèta-hydroxybutyrate in the context of important human pathophysiological states, including diabetes, epilepsy, and neoplasia.
- Shelf life instructionStable for 12 months from date of receipt/reconstitution.
- ReactivityHuman, Rat
- Reactivity SupplierHuman, Rat
- Reactivity Supplier NoteProtein A purified
- Storage InstructionStore at -20°C. Avoid freeze/thaw cycles.
- UNSPSC12352203
References
- Yufan Zheng, et al. 'bèta-hydroxybutyrate inhibits ferroptosis-mediated pancreatic damage in acute liver failure through the increase of H3K9bhb' Cell Reports (2022)Read more
- Ningning Chen, et al. 'Lysine bèta-hydroxybutyrylation promotes lipid accumulation in alcoholic liver disease' BIOCHEMICAL PHARMACOLOGY (2023)Read more